Teva Pharma Company Insiders

TEVA Stock  USD 16.10  0.14  0.86%   
Teva Pharma employs about 33.9 K people. The company is managed by 38 executives with a total tenure of roughly 180 years, averaging almost 4.0 years of service per executive, having 891.89 employees per reported executive. Analysis of Teva Pharma's management performance can provide insight into the company performance.
Kaare Schultz  CEO
President, Chief Executive Officer, Director
Amir Elstein  Chairman
Vice Chairman of the Board
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Teva Pharma Management Team Effectiveness

The company has return on total asset (ROA) of 0.0509 % which means that it generated a profit of $0.0509 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.283) %, meaning that it created substantial loss on money invested by shareholders. Teva Pharma's management efficiency ratios could be used to measure how well Teva Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Teva Pharma Workforce Comparison

Teva Pharma Industries is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 186,669. Teva Pharma retains roughly 33,892 in number of employees claiming about 18% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Teva Pharma Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teva Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teva Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Teva Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Teva Pharma Notable Stakeholders

A Teva Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Teva Pharma often face trade-offs trying to please all of them. Teva Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Teva Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard FrancisCEO PresidentProfile
Kaare SchultzPresident, Chief Executive Officer, DirectorProfile
Amir ElsteinVice Chairman of the BoardProfile
Sol BarerIndependent Chairman of the BoardProfile
Richard DaniellExecutive Vice President - European CommercialProfile
Mark SabagExecutive Vice President, Chief Human Resources Officer and Global Communications and BrandProfile
Gianfranco NazziExecutive Vice President - International Markets CommercialProfile
Brendan OGradyExecutive Vice President - North America CommercialProfile
Hafrun FridriksdottirExecutive Vice President and Presidentident of Global Generics R&DProfile
Eliyahu KalifChief Financial Officer, Executive Vice PresidentProfile
Kathleen VeitGlobal PresidentProfile
David StarkExecutive Vice President, Chief Legal OfficerProfile
Sven DethlefsExecutive Vice President - Global Marketing & Portfolio and International Markets CommercialProfile
Nechemia PeresIndependent DirectorProfile
JeanMichel HalfonStatutory - independent directorProfile
Perry NisenIndependent DirectorProfile
Gerald LiebermanIndependent DirectorProfile
Roberto MignoneIndependent DirectorProfile
Rosemary CraneIndependent DirectorProfile
Kevin MannixHead of Global Investor Relations and VPProfile
Matthew ShieldsExecutive OperationsProfile
Ronit SatchiFainaroIndependent DirectorProfile
Kare SchultzCEO PresProfile
Janet VergisIndependent DirectorProfile
Amir WeissSenior Vice President Chief Accounting OfficerProfile
Christopher CFASenior IntelligenceProfile
Galia InbarExecutive Vice President - Global Communications, Brand and ESG, Chief Human Resource OfficerProfile
Eli ShaniExecutive Vice President - Global Marketing and PortfolioProfile
Abbas HussainIndependent DirectorProfile
Eric DrapeExecutive Vice President - Global OperationsProfile
Vikki ConwayActing ResourcesProfile
Advocate BaronSenior AuditorProfile
Ran MeirHead RelationsProfile
David JDExecutive OfficerProfile
Placid JoverExecutive CHROProfile
Tal ZaksIndependent DirectorProfile
Andrew WeilChief Accounting OfficerProfile
Dov BergwerkActing SecretaryProfile

About Teva Pharma Management Performance

The success or failure of an entity such as Teva Pharma Industries often depends on how effective the management is. Teva Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Teva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Teva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States.
Please note, the presentation of Teva Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharma's management manipulating its earnings.

Teva Pharma Workforce Analysis

Traditionally, organizations such as Teva Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Teva Pharma within its industry.

Teva Pharma Manpower Efficiency

Return on Teva Pharma Manpower

Revenue Per Employee488.1K
Revenue Per Executive435.4M
Net Loss Per Employee57.8K
Net Loss Per Executive51.6M

Complementary Tools for Teva Stock analysis

When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets